(N-phthalimidoalkyl) piperidines useful as treatments for psychosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 1994
Issued Date -
N/A
app pub date -
Apr 30, 1992
filing date -
Oct 27, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
There is described novel (N-phthalimidoalkyl) piperidine compounds which exhibit selective sigma-receptor antagonism and therefore are useful in the treatment of physiological or drug induced psychosis and dyskinesia in a mammal. Also described are pharmaceutical compositions containing sigma selective compounds and methods of using these compositions for treating physiological or drug induced psychosis or dyskinesia in a mammal. Further provided are methods for preparing the compounds of this invention.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully